Cargando…
Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?
This article reviews the basic tenets of a clinical approach to effective immunotherapy of Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI). Although one randomized controlled study in early MCI patients by fish-derived omega-3 fatty acids (ω-3) showed slowing of disease pro...
Autores principales: | Fiala, Milan, Restrepo, Lucas, Pellegrini, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870008/ https://www.ncbi.nlm.nih.gov/pubmed/29103035 http://dx.doi.org/10.3233/JAD-170579 |
Ejemplares similares
-
Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation
por: Famenini, Sam, et al.
Publicado: (2017) -
Relevance of ω-6 GLA Added to ω-3 PUFAs Supplements for ADHD: A Narrative Review
por: D’Helft, Jelle, et al.
Publicado: (2022) -
ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
por: D’Angelo, Stefania, et al.
Publicado: (2020) -
Increased ω6-Containing Phospholipids and Primary ω6 Oxidation Products in the Brain Tissue of Rats on an ω3-Deficient Diet
por: Axelsen, Paul H., et al.
Publicado: (2016) -
The importance of a balanced ω-6 to ω-3 ratio in the prevention and management of obesity
por: Simopoulos, Artemis P, et al.
Publicado: (2016)